Moschen AR - Search Results

1

IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting.

Moschen AR, Tilg H, Raine T. Moschen AR, et al. Nat Rev Gastroenterol Hepatol. 2019 Mar;16(3):185-196. doi: 10.1038/s41575-018-0084-8. Nat Rev Gastroenterol Hepatol. 2019. PMID: 30478416 Review.

2

Increased expression of CCL20 in human inflammatory bowel disease.

Kaser A, Ludwiczek O, Holzmann S, Moschen AR, Weiss G, Enrich B, Graziadei I, Dunzendorfer S, Wiedermann CJ, Mürzl E, Grasl E, Jasarevic Z, Romani N, Offner FA, Tilg H. Kaser A, et al. Among authors: moschen ar. J Clin Immunol. 2004 Jan;24(1):74-85. doi: 10.1023/B:JOCI.0000018066.46279.6b. J Clin Immunol. 2004. PMID: 14997037

3

Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease.

Wolf AM, Wolf D, Rumpold H, Moschen AR, Kaser A, Obrist P, Fuchs D, Brandacher G, Winkler C, Geboes K, Rutgeerts P, Tilg H. Wolf AM, et al. Among authors: moschen ar. Clin Immunol. 2004 Oct;113(1):47-55. doi: 10.1016/j.clim.2004.05.004. Clin Immunol. 2004. PMID: 15380529

4

Adiponectin and its receptors in non-alcoholic steatohepatitis.

Kaser S, Moschen A, Cayon A, Kaser A, Crespo J, Pons-Romero F, Ebenbichler CF, Patsch JR, Tilg H. Kaser S, et al. Gut. 2005 Jan;54(1):117-21. doi: 10.1136/gut.2003.037010. Gut. 2005. PMID: 15591515 Free PMC article.

5

The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss.

Moschen AR, Kaser A, Enrich B, Ludwiczek O, Gabriel M, Obrist P, Wolf AM, Tilg H. Moschen AR, et al. Gut. 2005 Apr;54(4):479-87. doi: 10.1136/gut.2004.044370. Gut. 2005. PMID: 15753532 Free PMC article.

6

Circulating adiponectin reflects severity of liver disease but not insulin sensitivity in liver cirrhosis.

Kaser S, Moschen A, Kaser A, Ludwiczek O, Ebenbichler CF, Vogel W, Jaschke W, Patsch JR, Tilg H. Kaser S, et al. J Intern Med. 2005 Sep;258(3):274-80. doi: 10.1111/j.1365-2796.2005.01543.x. J Intern Med. 2005. PMID: 16115302 Free article.

7

Adiponectin and its receptors in patients with chronic hepatitis C.

Jonsson JR, Moschen AR, Hickman IJ, Richardson MM, Kaser S, Clouston AD, Powell EE, Tilg H. Jonsson JR, et al. Among authors: moschen ar. J Hepatol. 2005 Dec;43(6):929-36. doi: 10.1016/j.jhep.2005.05.030. Epub 2005 Jul 1. J Hepatol. 2005. PMID: 16139921

8

The RANKL/OPG system and bone mineral density in patients with chronic liver disease.

Moschen AR, Kaser A, Stadlmann S, Millonig G, Kaser S, Mühllechner P, Habior A, Graziadei I, Vogel W, Tilg H. Moschen AR, et al. J Hepatol. 2005 Dec;43(6):973-83. doi: 10.1016/j.jhep.2005.05.034. Epub 2005 Jul 5. J Hepatol. 2005. PMID: 16143421

9

Up-regulation of the anti-inflammatory adipokine adiponectin in acute liver failure in mice.

Wolf AM, Wolf D, Avila MA, Moschen AR, Berasain C, Enrich B, Rumpold H, Tilg H. Wolf AM, et al. Among authors: moschen ar. J Hepatol. 2006 Mar;44(3):537-43. doi: 10.1016/j.jhep.2005.08.019. Epub 2005 Sep 23. J Hepatol. 2006. PMID: 16310276 Free article.

10

The impact of prolonged strenuous endurance exercise on interleukin 18 and interleukin 18 binding protein in recreational cyclists.

Neumayr G, Ludwiczek O, Hoertnagl H, Pfister R, Mitterbauer G, Moschen A, Novick D, Rubinstein M, Tilg H. Neumayr G, et al. Int J Sports Med. 2005 Dec;26(10):836-40. doi: 10.1055/s-2005-837466. Int J Sports Med. 2005. PMID: 16320167

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters